Omission of Hemostatic Agents During Robotic Partial Nephrectomy Does Not Increase Postoperative Bleeding Risk

Area of Science:

• Urology
• Surgical Innovation
• Hemostasis

Background:

• Hemostatic agents (HA) are empirically used in robotic partial nephrectomy (RPN), but their impact on postoperative bleeding is unclear.
• Current practices often rely on anecdotal evidence rather than robust data for HA application in RPN.

Purpose of the Study:

• To evaluate the effectiveness of hemostatic agents in reducing postoperative bleeding after RPN.
• To analyze the association between HA use and outcomes such as blood transfusion and hemoglobin decline in RPN patients.

Main Methods:

• A retrospective analysis of consecutive RPN cases between 2010 and 2015 was conducted.
• Patients were stratified based on HA use, excluding those with preoperative anemia or high estimated blood loss.
• Postoperative bleeding outcomes (transfusion, hemoglobin decline) were compared between groups.

Main Results:

• Hemostatic agents were used in 44.1% of cases, with a mean cost of $488 per case.
• Univariate analysis showed an association between HA use and hemoglobin decline, but not blood transfusion.
• After adjusting for covariates, HA use was not significantly associated with postoperative hemoglobin decline.

Conclusions:

• Hemostatic agent use does not appear to improve postoperative bleeding outcomes in nonanemic RPN patients with minimal intraoperative bleeding.
• The routine application of HA in RPN may warrant reevaluation, particularly in lower-risk patient populations.
• Further research is needed to identify specific high-risk scenarios where hemostatic agents might be beneficial.